These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8346730)

  • 21. Long-term efficacy of d/l sotalol in patients with sustained ventricular tachycardia refractory to class I antiarrhythmic drugs.
    Kühlkamp V; Mermi J; Mewis C; Braun U; Seipel L
    Eur Heart J; 1995 Nov; 16(11):1625-31. PubMed ID: 8881857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic drugs and ventricular defibrillation energy requirements.
    Qi X; Dorian P
    Chin Med J (Engl); 1999 Dec; 112(12):1147-52. PubMed ID: 11721458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
    N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transthoracic defibrillation of short-lasting ventricular fibrillation: a randomised trial for comparison of the efficacy of low-energy biphasic rectilinear and monophasic damped sine shocks.
    Szili-Torok T; Theuns D; Verblaauw T; Scholten M; Kimman GJ; Res J; Jordaens L
    Acta Cardiol; 2002 Oct; 57(5):329-34. PubMed ID: 12405569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chronic oral moricizine and intravenous epinephrine on ventricular fibrillation and defibrillation thresholds.
    Pharand C; Goldman R; Fan C; Chow M; Kluger J
    Pacing Clin Electrophysiol; 1996 Jan; 19(1):82-9. PubMed ID: 8848382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between implantable cardioverter-defibrillators and class III agents.
    Movsowitz C; Marchlinski FE
    Am J Cardiol; 1998 Aug; 82(4A):41I-48I. PubMed ID: 9737653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of ventricular vulnerable period and ventricular fibrillation threshold by use of T-wave shocks in patients undergoing implantation of cardioverter/defibrillators.
    Hou CJ; Chang-Sing P; Flynn E; Martinez L; Peterson J; Ottoboni LK; Liem LB; Sung RJ
    Circulation; 1995 Nov; 92(9):2558-64. PubMed ID: 7586357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioversion, defibrillation, and overdrive pacing of ventricular arrhythmias: the effect of moricizine in dogs with sustained monomorphic ventricular tachycardia.
    Avitall B; Hare J; Zander G; Lessila C; Dhala A; Deshpande S; Jazayeri M; Sra J; Akhtar M
    Pacing Clin Electrophysiol; 1993 Nov; 16(11):2092-7. PubMed ID: 7505920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest.
    Haverkamp W; Eckardt L; Borggrefe M; Breithardt G
    Am J Cardiol; 1997 Oct; 80(8A):67G-73G. PubMed ID: 9354413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of procainamide and sotalol on restitution properties, dispersion of refractoriness, and ventricular fibrillation activation patterns in pigs.
    Jin Q; Chen X; Smith WM; Ideker RE; Huang J
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1090-7. PubMed ID: 18479337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of induction method on defibrillation threshold and ventricular fibrillation cycle length.
    Zima E; Gergely M; Soós P; Gellér LA; Nemes A; Acsády G; Merkely B
    J Cardiovasc Electrophysiol; 2006 Apr; 17(4):377-81. PubMed ID: 16643358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of successful defibrillation threshold test during CRT-D implantation.
    Przybylski A; Oreziak A; Lewandowski Z; Hasiec A; Orczykowski M; Walczak F
    Kardiol Pol; 2010 May; 68(5):512-8. PubMed ID: 20491010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular fibrillation with small amplitude of activation and its implications for implantable cardioverter defibrillator treatment.
    Chinushi M; Kasai H; Tagawa M; Washizuka T; Aizawa Y
    Jpn Heart J; 1999 Jan; 40(1):87-90. PubMed ID: 10370401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization.
    Aizawa Y; Chinushi M; Hasegawa K; Naiki N; Horie M; Kaneko Y; Kurabayashi M; Ito S; Imaizumi T; Aizawa Y; Takatsuki S; Joo K; Sato M; Ebe K; Hosaka Y; Haissaguerre M; Fukuda K
    J Am Coll Cardiol; 2013 Sep; 62(11):1015-9. PubMed ID: 23747791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventricular pacing threshold and refractoriness after defibrillation shocks in patients with implantable cardioverter-defibrillators.
    Yu JC; Lauer MR; Young C; Liem B; Peterson J; Ottoboni L; Sung RJ
    Am Heart J; 1996 Jun; 131(6):1121-6. PubMed ID: 8644590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric defibrillation doses often fail to terminate prolonged out-of-hospital ventricular fibrillation in children.
    Berg MD; Samson RA; Meyer RJ; Clark LL; Valenzuela TD; Berg RA
    Resuscitation; 2005 Oct; 67(1):63-7. PubMed ID: 16199288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator.
    Marchlinski FE; Flores B; Miller JM; Gottlieb CD; Hargrove WC
    Am J Cardiol; 1988 Sep; 62(7):393-8. PubMed ID: 3414516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.